AUROPHARMA

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Aurobindo Pharma Limited

Aurobindo Pharma Limited is a biopharmaceutical company in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic. It develops, manufactures, commercializes, ...

हिन्दी में

ऑरोबिंदो फार्मा लिमिटेड Healthcare सेक्टर में एक बायोफार्मास्युटिकल कंपनी है, जो विशेष रूप से ड्रग मैन्युफैक्चरर्स - स्पेशलिटी और जेनेरिक उप-क्षेत्र में है। यह जेनेरिक फार्मास्युटि...

₹1,693+2.92%1D
Previous trading day close · Data updates after market close
1W: +1.1%
1M: -0.3%
6M: +26.4%
1Y: +54.4%
71/100
GoodResearch Score
Market Cap
₹89.4K Cr
Large Cap
P/E Ratio
26.60
Fair
P/B Ratio
2.86
Reasonable
ROE
11.2%
Weak
ROCE
15.8%
Good
Debt / Equity
0.25
Low debt
Div. Yield
0.3%
EV/EBITDA
12.82
Attractive
52W Low: ₹1,066.8Current: ₹1,69352W High: ₹1,740
At 93% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
68/100
Growth
Revenue, EPS, profit growth
82/100
Valuation
PE, PB, EV/EBITDA vs sector
62/100
Risk
Debt levels, volatility, coverage
86/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
26.60(Fair)
Forward P/E
20.85(Premium)
P/B Ratio
2.86(Reasonable)
P/S Ratio
2.73(Good)
EV/EBITDA
12.82(Attractive)
Dividend Yield
0.3%
5Y CAGR
10.3%(Moderate)
Revenue Growth
5.6%(Moderate)
Profitability
ROE
11.2%(Average)
ROCE
15.8%(Good)
ROA
7.4%(Average)
Net Margin
10.3%(Decent)
EBITDA Margin
21.3%
Financial Health
Debt to Equity
0.25(Low debt)
Current Ratio
1.85(Healthy)
Quick Ratio
1.13(Good)
Interest Coverage
14.31x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
41(Neutral)
RSI Exp (14)
44(Neutral)
MACD
6.220(Bullish)
MACD Signal
11.860
BB Position
55%(Middle)
BB Width
5.78%(Normal)
ADX (14)
16.6(Sideways)
Williams %R
-43.9(Neutral)
MFI (14)
65(Neutral)
CCI (20)
-43(Neutral)
Stoch %K
56(Neutral)
ATR (14)
35.55(Avg True Range)
OBV (M)
6.8(Positive)
1W OBV Chg
-1.8%(Decreasing)
Rel Volume
0.81x(Normal)
Volatility
27.5%(Moderate)
Max DD 1Y
-32.3%(Moderate)
EMA 200
1476.4
EMA 50
1650.2
SMA 200
1429.4
vs SMA 50
2.2%(Above SMA50)
vs SMA 200
18.4%(Above SMA200)
Volume
6.99L
Avg Vol 3M
8.7L
Shareholding Pattern
Promoter
51.8%
High confidence
FII
15.2%
DII / MF
25.9%
Strong MF interest
Share AUROPHARMA
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.